Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
- PMID: 27177534
- PMCID: PMC5013109
- DOI: 10.1136/heartjnl-2016-309359
Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
Abstract
Objective: To assess the accuracy of Global Registry of Acute Coronary Events (GRACE) scores in predicting mortality at 6 months for people with chronic obstructive pulmonary disease (COPD) and to investigate how it might be improved.
Methods: Data were obtained on 481 849 patients with acute coronary syndrome admitted to UK hospitals between January 2003 and June 2013 from the Myocardial Ischaemia National Audit Project (MINAP) database. We compared risk of death between patients with COPD and those without COPD at 6 months, adjusting for predicted risk of death. We then assessed whether several modifications improved the accuracy of the GRACE score for people with COPD.
Results: The risk of death after adjusting for GRACE score predicted that risk of death was higher for patients with COPD than that for other patients (RR 1.29, 95% CI 1.28 to 1.33). Adding smoking into the GRACE score model did not improve accuracy for patients with COPD. Either adding COPD into the model (relative risk (RR) 1.00, 0.94 to 1.02) or multiplying the GRACE score by 1.3 resulted in better performance (RR 0.99, 0.96 to 1.01).
Conclusions: GRACE scores underestimate risk of death for people with COPD. A more accurate prediction of risk of death can be obtained by adding COPD into the GRACE score equation, or by multiplying the GRACE score predicted risk of death by 1.3 for people with COPD. This means that one third of patients with COPD currently classified as low risk should be classified as moderate risk, and could be considered for more aggressive early treatment after non-ST-segment elevation myocardial infarction or unstable angina.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures


Comment in
-
Is there still a place for improvement in acute coronary syndrome risk stratification?Heart. 2016 Sep 15;102(18):1423-4. doi: 10.1136/heartjnl-2016-309860. Epub 2016 Jun 9. Heart. 2016. PMID: 27288282 No abstract available.
Similar articles
-
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.Vasc Health Risk Manag. 2016 Nov 21;12:471-476. doi: 10.2147/VHRM.S117204. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27920547 Free PMC article.
-
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):198-213. doi: 10.1093/ehjcvp/pvw049. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28329196
-
Early Invasive Versus Initial Conservative Strategies for Women with Non-ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis.Am J Med. 2017 Sep;130(9):1059-1067. doi: 10.1016/j.amjmed.2017.01.049. Epub 2017 Feb 24. Am J Med. 2017. PMID: 28238691
-
Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006363. doi: 10.1161/CIRCOUTCOMES.119.006363. Epub 2020 Feb 17. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32063040 Free PMC article.
-
Contemporary Revascularization Dilemmas in Older Adults.J Am Heart Assoc. 2020 Feb 4;9(3):e014477. doi: 10.1161/JAHA.119.014477. Epub 2020 Jan 24. J Am Heart Assoc. 2020. PMID: 31973608 Free PMC article. Review. No abstract available.
Cited by
-
Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude.High Alt Med Biol. 2023 Sep;24(3):158-166. doi: 10.1089/ham.2023.0053. Epub 2023 Aug 30. High Alt Med Biol. 2023. PMID: 37646641 Free PMC article.
-
Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndrome.Clin Epigenetics. 2021 Apr 15;13(1):79. doi: 10.1186/s13148-021-01066-w. Clin Epigenetics. 2021. PMID: 33858475 Free PMC article.
-
Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial.Eur Respir J. 2024 Feb 1;63(2):2202353. doi: 10.1183/13993003.02353-2022. Print 2024 Feb. Eur Respir J. 2024. PMID: 38123239 Free PMC article. Clinical Trial.
-
Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study.Ann Intern Med. 2020 Jan 7;172(1):12-21. doi: 10.7326/M19-0974. Epub 2019 Dec 10. Ann Intern Med. 2020. PMID: 31816630 Free PMC article.
-
Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry.BMJ Open. 2023 Mar 29;13(3):e069505. doi: 10.1136/bmjopen-2022-069505. BMJ Open. 2023. PMID: 36990493 Free PMC article.
References
-
- Collinson J, Flather MD, Fox KAA, et al. . Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000;21:1450–7. - PubMed
-
- de Araújo Gonçalves P, Ferreira J, Aguiar C, et al. . TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865–72. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical